BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12006674)

  • 1. A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse.
    Daly CJ; Deighan C; McGee A; Mennie D; Ali Z; McBride M; McGrath JC
    Physiol Genomics; 2002; 9(2):85-91. PubMed ID: 12006674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.
    Hosoda C; Tanoue A; Shibano M; Tanaka Y; Hiroyama M; Koshimizu TA; Cotecchia S; Kitamura T; Tsujimoto G; Koike K
    Br J Pharmacol; 2005 Oct; 146(3):456-66. PubMed ID: 16113694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.
    Methven L; McBride M; Wallace GA; McGrath JC
    Br J Pharmacol; 2009 Sep; 158(1):209-24. PubMed ID: 19572943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating alpha2-adrenoceptors.
    Flavahan NA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):432-9. PubMed ID: 15608085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes.
    Methven L; Simpson PC; McGrath JC
    Br J Pharmacol; 2009 Dec; 158(7):1663-75. PubMed ID: 19888965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium.
    Shafaroudi MM; McBride M; Deighan C; Wokoma A; Macmillan J; Daly CJ; McGrath JC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):804-10. PubMed ID: 15878998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylephrine contracts porcine pulmonary veins via alpha(1B)-, alpha(1D)-, and alpha(2)-adrenoceptors.
    Görnemann T; Villalón CM; Centurión D; Pertz HH
    Eur J Pharmacol; 2009 Jun; 613(1-3):86-92. PubMed ID: 19376108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes.
    Chalothorn D; McCune DF; Edelmann SE; Tobita K; Keller BB; Lasley RD; Perez DM; Tanoue A; Tsujimoto G; Post GR; Piascik MT
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1045-53. PubMed ID: 12649302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of α1-adrenoceptor subtypes in murine ophthalmic arteries.
    Gericke A; Kordasz ML; Steege A; Sanbe A; Goloborodko E; Vetter JM; Patzak A; Pfeiffer N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4795-9. PubMed ID: 21613371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced vascular contractility in alpha1-adrenergic receptor-deficient mice.
    Sanbe A; Tanaka Y; Fujiwara Y; Miyauchi N; Mizutani R; Yamauchi J; Cotecchia S; Koike K; Tsujimoto G; Tanoue A
    Life Sci; 2009 May; 84(21-22):713-8. PubMed ID: 19249315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction.
    Townsend SA; Jung AS; Hoe YS; Lefkowitz RY; Khan SA; Lemmon CA; Harrison RW; Lee K; Barouch LA; Cotecchia S; Shoukas AA; Nyhan D; Hare JM; Berkowitz DE
    Hypertension; 2004 Nov; 44(5):776-82. PubMed ID: 15466664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-specific alteration of adrenergic responses in small femoral arteries from estrogen receptor-beta knockout mice.
    Luksha L; Poston L; Gustafsson JA; Aghajanova L; Kublickiene K
    Hypertension; 2005 Nov; 46(5):1163-8. PubMed ID: 16216990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
    Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
    Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
    Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
    J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
    Brasili L; Sorbi C; Franchini S; Manicardi M; Angeli P; Marucci G; Leonardi A; Poggesi E
    J Med Chem; 2003 Apr; 46(8):1504-11. PubMed ID: 12672251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1B adrenoceptors mediate neurogenic constriction in mesenteric arteries of normotensive and DOCA-salt hypertensive mice.
    Pérez-Rivera AA; Fink GD; Galligan JJ
    Auton Neurosci; 2005 Aug; 121(1-2):64-73. PubMed ID: 16095979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells.
    Israilova M; Tanaka T; Suzuki F; Morishima S; Muramatsu I
    J Pharmacol Exp Ther; 2004 Apr; 309(1):259-66. PubMed ID: 14722320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo endothelial denudation disrupts smooth muscle caveolae and differentially impairs agonist-induced constriction in small arteries.
    Bailey SR; Mitra S; Flavahan S; Bergdall VK; Flavahan NA
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):183-90. PubMed ID: 17438402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.